1. Home
  2. SRRK vs ICUI Comparison

SRRK vs ICUI Comparison

Compare SRRK & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRRK
  • ICUI
  • Stock Information
  • Founded
  • SRRK 2012
  • ICUI 1984
  • Country
  • SRRK United States
  • ICUI United States
  • Employees
  • SRRK N/A
  • ICUI N/A
  • Industry
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • ICUI Medical/Dental Instruments
  • Sector
  • SRRK Health Care
  • ICUI Health Care
  • Exchange
  • SRRK Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • SRRK 3.1B
  • ICUI 3.5B
  • IPO Year
  • SRRK 2018
  • ICUI 1992
  • Fundamental
  • Price
  • SRRK $30.67
  • ICUI $138.30
  • Analyst Decision
  • SRRK Strong Buy
  • ICUI Strong Buy
  • Analyst Count
  • SRRK 6
  • ICUI 5
  • Target Price
  • SRRK $42.17
  • ICUI $196.75
  • AVG Volume (30 Days)
  • SRRK 1.3M
  • ICUI 274.8K
  • Earning Date
  • SRRK 05-14-2025
  • ICUI 05-08-2025
  • Dividend Yield
  • SRRK N/A
  • ICUI N/A
  • EPS Growth
  • SRRK N/A
  • ICUI N/A
  • EPS
  • SRRK N/A
  • ICUI N/A
  • Revenue
  • SRRK N/A
  • ICUI $2,420,093,000.00
  • Revenue This Year
  • SRRK N/A
  • ICUI $0.84
  • Revenue Next Year
  • SRRK $601.05
  • ICUI $2.91
  • P/E Ratio
  • SRRK N/A
  • ICUI N/A
  • Revenue Growth
  • SRRK N/A
  • ICUI 7.22
  • 52 Week Low
  • SRRK $6.76
  • ICUI $95.44
  • 52 Week High
  • SRRK $46.98
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • SRRK 47.15
  • ICUI 49.24
  • Support Level
  • SRRK $28.76
  • ICUI $131.73
  • Resistance Level
  • SRRK $33.48
  • ICUI $142.00
  • Average True Range (ATR)
  • SRRK 1.71
  • ICUI 6.49
  • MACD
  • SRRK -0.04
  • ICUI 0.67
  • Stochastic Oscillator
  • SRRK 32.60
  • ICUI 57.04

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: